Department of the Navy May 7, 2015 – Federal Register Recent Federal Regulation Documents
Results 1 - 2 of 2
Notice of Intent To Grant Partially Exclusive Patent License; Epitracker, LLC
The Department of the Navy hereby gives notice of its intent to grant to Epitracker, LLC, a revocable, nonassignable, partially exclusive license in the United States to practice the Government-Owned inventions described in U.S. Patent Application No. 14/591660``Use of heptadecanoic acid (C17:0) to detect risk of and treat hyperferritinemia and metabolic syndrome''.
Notice of Availability of Government-Owned Inventions; Available for Licensing
The following invention is assigned to the United States Government as represented by the Secretary of the Navy and made available for licensing by the Department of the Navy: U.S. Patent Application No. 14/591660``Use of heptadecanoic acid (C17:0) to detect risk of and treat hyperferritinemia and metabolic syndrome''.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
